Sarah L. Bliese, Ph.D. is an analytical chemist within the Medicines for All Institute where she generates and implements analytical methods to support process development for the Institute’s various projects. Previously she worked on the development of paper-based screening devices for monitoring pharmaceuticals during post-market surveillance studies in low- and middle-income countries. Sarah holds a B.S. in biology and B.S. in chemistry from Hamline University in St. Paul, MN and a Ph.D. in analytical chemistry from the University of Notre Dame.
Justina Burns, Ph.D. generates analytical chemistry methods to support process development at the Medicines for All Institute. Previously she worked in contract research supporting a variety of projects which included sample preparation/analysis, report writing and training. Additionally, Justina worked in the Mass Spectrometry Center at the University of South Carolina focusing on ICP-MS. She holds a B.S. in chemistry from University of Pittsburgh, Johnstown and a Ph.D. in analytical environmental chemistry from the University of South Carolina.
Flavio Cardoso, Ph.D., is a research scientist at Medicines for All Institute working on process development of APIs and/or key building blocks. Prior to joining M4ALL, he worked at Libbs Pharmaceuticals as R&D Coordinator where he gained experience in the development of synthetic processes for the manufacture of generic APIs. He holds a Ph.D. in organic chemistry from the University of Florida, where he designed and applied StackPhos, a new chiral biaryl heterocyclic ligand for enantioselective catalysis. Dr. Cardoso obtained his B.S. at UNICAMP (Brazil), where he applied palladium catalyzed cross-coupling reactions for the synthesis of biologically active compounds.
Daniel W. Cook, PhD is an analytical chemist within the Medicines for All Institute where he utilizes his expertise in separation sciences and chemometrics to develop and implement analytical methods to support the Institute’s various projects. He holds a B.S in chemistry from Randolph-Macon College in Ashland, VA and a Ph.D. in chemistry from VCU. Prior to his current role at M4ALL, he held a postdoctoral fellowship at VCU in the Chemical and Life Science Engineering department working on both the Pharmacy on Demand project under Dr. Thomas Roper and M4ALL under Dr. Frank Gupton. He transitioned into his current role in early 2019.
Aravindan Jayaraman, Ph.D. obtained his BSc and MSc in Chemistry from Sacred Heart College in India. After earning his MSc, he began his career as a Process Chemist with Syngene International Limited, Biocon Company where he worked with various clients (Dupont, BMS) for 7 years. During his time with Syngene, he was promoted to Senior Associate Scientist after gaining significant expertise in various process development, route scouting, tech-transfer and scale-up (lab and pilot plant). He brings experience coordinating with analytical and engineering teams to develop robust processes to commercialize in the market. He obtained his doctorate from Chonnam National University, South Korea followed by postdoctoral research at Kansas State University. He was also a NIH postdoctoral researcher at Albany College of Pharmacy and Health Sciences.
Ryan Nelson, Ph.D., is a research scientist who joined the M4ALL team in the summer of 2019. His contributions to the group range from on-paper route development to benchtop route scouting and scale up. Previously, Ryan was a faculty member at Bowdoin and Bates Colleges in Maine, where he taught a variety of chemistry courses and contributed to several collaborative research projects. Ryan received his bachelor’s degree from Gustavus Adolphus College and his Ph.D. from the University of Wisconsin-Madison. He also held post-doctoral research positions at Argonne National Laboratory and University of California, Santa Barbara.
Dinesh J. Paymode, Ph.D., received his bachelor’s and master’s degree from University of Pune, Pune, India. In 2012, he associated with Dr. C. V. Ramana research group at CSIR–National Chemical Laboratory, Pune for his doctoral studies. During his Ph.D., he worked on total synthesis of allocolchicine, parvifolal A/B and Ru–catalyzed C–H activation. Later, in 2018, he joined Dr. Sharma’s lab as a postdoctoral fellow at University of Oklahoma, where he focused on Rh-carbenoid initiated cascades for the synthesis of diverse heterocycles. Currently, he is a postdoctoral fellow in Dr. Gupton’s laboratory and Medicines for All. He is working on drug discovery and process development to access active pharmaceutical ingredients (APIs).
Tai holds BSc and MPhil degrees from the University of Hong Kong, and PhD in organic chemistry from Imperial College London on a British Commonwealth scholarship. He completed his postdoctoral training in organic synthesis at the Scripps Research Institute. Tai worked as a process chemist in the pharmaceutical industry for 18 years (DuPont Pharmaceutical, BMS, and Incyte). He was senior director of process chemistry at Incyte prior to joining the Clinton Health Access Initiative as scientific director in 2015.
Roudabeh Pourasil obtained her Ph.D. in Chemometrics, Analytical Chemistry at Sharif University of Technology, Tehran, Iran, in 2014. Her research focuses on the application of mathematical and statistical methods to evaluate data and analytical measurements. Dr. Moazeni combines chemometrics and analytical chemistry for use in areas such as biology, pharmaceuticals, chemistry, chemical engineering, food and environmental sciences. Her slogan is to “Help and make the people of the world be healthier and happier”. She joined Medicines for All Institute at VCU to develop process analytical technologies and chemometric models which can monitor the quality of pharmaceutical processes.